A Phase 1 Study to Assess the Effect of Severe Renal Impairment on the Pharmacokinetics, as Well as Safety/Tolerability, of Ranolazine
Condition(s):Severe Renal ImpairmentLast Updated:December 6, 2012Terminated
Hide Studies Not Open or Pending
Condition(s):Severe Renal ImpairmentLast Updated:December 6, 2012Terminated
Condition(s):Coronary Artery DiseaseLast Updated:March 26, 2014Unknown status
Condition(s):Atrial FibrillationLast Updated:November 6, 2020Completed
Condition(s):Atherosclerotic Coronary Vascular DiseaseLast Updated:June 18, 2021Terminated
Condition(s):Silent Myocardial Ischemia; Type 2 DiabetesLast Updated:May 17, 2017Withdrawn
Condition(s):Persistent Atrial FibrillationLast Updated:August 19, 2014Completed
Condition(s):Coronary Artery Disease,Last Updated:March 14, 2013Unknown status
Condition(s):Pulmonary Arterial HypertensionLast Updated:March 3, 2017Completed
Condition(s):Severe Coronary Artery Disease; Ischaemic Myocardial DysfunctionLast Updated:April 10, 2018Withdrawn
Condition(s):Chronic Stable AnginaLast Updated:December 12, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.